SciELO - Scientific Electronic Library Online

 
vol.79 número12Uveítis recurrentes y tratamiento con anticuerpos monoclonales (Daclizumab)Influencia del LASIK en la capa de fibras nerviosas retinianas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Archivos de la Sociedad Española de Oftalmología

versión impresa ISSN 0365-6691

Resumen

TORRES, RM; YANEZ, B; HERRERAS, JM  y  CALONGE, M. Ocular Behçet disease: Retrospective study. Arch Soc Esp Oftalmol [online]. 2004, vol.79, n.12, pp.599-604. ISSN 0365-6691.

Objective: To study clinical features, visual prognosis and response to immunosuppressive drugs in patients with ocular Behçet Disease (BD). Patients and methods: clinical data of 17 patients (33 eyes) were retrospectively reviewed from May 1996 to May 2003. Results: The male/female ratio was 12/5. The commonest manifestations were oral ulceration (100%) and skin lesions (88%). Anterior uveitis was present in 59%, posterior uveitis was in 76% and panuveitis was in 88.1%. Visual acuity improved in 11 (33.3%) eyes, remind stable in 18 (54.5%) eyes and four (12.1%) eyes lost two or more lines. Main drug therapy consisted of colchicine and cyclosporine (59%). Seven patients had received three drugs simultaneously. Conclusions: BD can lead to an irreversible visual loss; however, the visual prognosis is good (85%) if immunosuppressor treatment is implemented.

Palabras clave : Uveitis; Behçet’s disease; immunosuppressors; treatment.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons